If You'd Invested Rs 10,000 in SRF 10 Years Ago, Here's How Much You'd Have Today

The Indian chemical sector stands as the backbone of the economy, ranking 6th globally and 3rd in Asia.

With a diverse portfolio spanning over 80,000 commercial products-including bulk and speciality chemicals, petrochemicals, agrochemicals, fertilizers, and polymers, the industry continues to evolve at a rapid pace.

Amid this thriving ecosystem, SRF has carved out a legacy of excellence. Specializing in industrial and speciality chemicals, packaging films, and technical textiles, the company has not just expanded its footprint but has also emerged as a formidable wealth creator.

About SRF

SRF is a leading manufacturer of fluorochemicals and speciality chemicals, including refrigerants, pharma propellants, and industrial chemicals.

With a diverse product portfolio and a strong market presence, the company holds leadership positions across several of its product categories. Its chemicals primarily cater to the agriculture and pharmaceutical industries, playing a crucial role in these sectors.

Beyond chemicals, SRF is also engaged in manufacturing packaging films and a variety of technical textiles, such as belting fabrics, tyre cord fabrics, polyester industrial yarn, and coated and laminated fabrics.

The company has a significant global footprint, exporting its products to over 100 countries and operating manufacturing facilities in India, Thailand, South Africa, and Hungary.

SRF vs Sensex

SRF's share price has risen sharply from Rs 186.7 a decade ago to Rs 2,809.4 as on 6 February 2025.

If you had invested Rs 10,000 in the company 10 years ago, your investment would now be worth Rs 150,490. This is a growth of 1,404.9%.

In comparison, the Sensex has grown around 167.4% over the last decade, from 28,533 to 76,293 as on 11 February 2025.

Since its debut in 2002, the company's shares have skyrocketed by an extraordinary 138,302.9%. The stock has experienced a significant surge, particularly since April 2020.

What Sparked this Impressive Rally?

SRF's stock has witnessed a remarkable surge over the past decade, driven by its strategic expansion, market leadership, and favourable industry tailwinds.

The company has cemented its position as a dominant force in the fluorochemicals business, leveraging its expertise in fluorination and non-fluorinated chemistries.

Being among the top five global manufacturers of key fluorochemical products and one of the few worldwide producers of pharma-grade 134a/P-a crucial propellant used in metered dose inhalers-SRF has capitalized on rising demand in both industrial and pharmaceutical sectors.

Beyond chemicals, SRF's diversified business model has played a pivotal role in its growth.

The company holds a 40% market share in India's nylon tyre cord segment and ranks as the fifth-largest player globally, alongside being the world's second-largest manufacturer of conveyor belting fabrics.

These leadership positions have provided SRF with pricing power, operational efficiency, and sustained revenue growth.

A key driver of its decade-long rally has been its ability to capture opportunities arising from global shifts in supply chains.

The China Plus One strategy has worked in SRF's favour, as companies sought alternatives to Chinese suppliers, boosting demand for its products.

Additionally, its strong export footprint in over 100 countries has allowed the company to tap into diverse markets, ensuring resilience against domestic slowdowns.

Coupled with consistent investments in capacity expansion, R&D-driven product innovation, and strategic acquisitions, SRF has successfully scaled its business while delivering strong financial performance.

Additionally, over the years, the following key events have significantly contributed to the company's share price growth.

Year	Major Event	Impact on Business
2015	Acquired DuPontTM Dymel® HFA 134a/P	Became one of the few global manufacturers of pharma-grade HFA 134a/P, strengthening its fluorochemicals business.
2016	Fluorochemicals Thailand Operations	Expanded global footprint by setting up a distribution network for refrigerants and chemicals in Thailand.
2017	Packaging Films Business at Indore	Entered the flexible packaging sector in India with a new BOPET & BOPP films manufacturing facility.
	Acquired Mexichem’s HFC-125 Assets	Gained an exclusive technical advantage in manufacturing all three major HFCs under the FLORON® brand.
2018	Closure of SRF Industex Belting (Pty) Ltd.	Exited unviable operations in South Africa to optimize business focus.
2019	Sold Engineering Plastics Business to DSM	Strategic exit from non-core business, securing Rs 320 crore in an all-cash transaction.
	Closed Technical Textiles Plant in Thailand	Integrated capacities with India operations for better efficiency.
2020	Foray into Europe - Packaging Films Hungary	Established a BOPET film facility in Hungary to strengthen its European presence.
	2nd BOPET Film Line & Resin Plant in Thailand	Expanded capacity to meet rising global demand for flexible packaging.
2021	1st BOPP Film Line at Rayong, Thailand	Commissioned a high-speed BOPP film line, enhancing specialty product offerings.
2022	Incorporation of SRF Altech Limited	Entered the aluminium foil manufacturing segment through a wholly owned subsidiary.
2023	Foray into Fluoropolymers	Set up a state-of-the-art PTFE manufacturing facility at Dahej, diversifying its fluorochemical portfolio.
2024	Commissioning of Aluminium Foil Facility	Launched a GMP-compliant aluminium foil plant in Madhya Pradesh with a capacity of 20,000 MTPA.

Robust Financials

SRF's revenue rose 14% to Rs 34,913 million (m) in the December quarter. It was Rs 30,530 m in the December quarter a year ago.

It reported a net profit of Rs 2,711 m for the December 2024 quarter. It had posted a consolidated net loss of Rs 2,534 m in the December quarter a year ago.

Its revenue for FY24 was Rs 131,385 m, which was a 12% lower than the previous year's revenue of Rs 148,703 m. Its net profit for the year dropped 38.2% to Rs 13,357 m, down from Rs 21,623 m.

SRF Financial Snapshot (FY20-24)

(Rs m, Consolidated)	FY20	FY21	FY22	FY23	FY24
Revenue	72,094	84,000	124,337	148,703	131,385
Revenue Growth (%)	1.5	16.5	48	19.6	(-11.7)
Net Profit	9,159	11,983	18,889	21,623	13,357
Net Profit Margin (%)	12.7	14.3	15.2	14.5	10.2
Return on Equity (%)	18.6	17.5	22.1	21	11.7
Return on Capital Employed (%)	15.4	19.8	26.2	24	14.5

Source: Equitymaster

From FY20 to FY24, the company achieved a CAGR growth of 13.1% in sales, while its net profit saw a growth by 17.7%.

Additionally, SRF has consistently maintained decent financial metrics, with an average return on equity (RoE) of 18.1% and a return on capital employed (RoCE) of 20%.

What Next?

On 22 October 2024, SRF's board approved two major expansion projects, a 4^th generation refrigeration plant and a BOPP-BOPE film manufacturing facility (including a metallizer) at Indore.

The total investment for these projects is estimated at Rs 15.45 billion (bn).

The company plans to establish a new facility for manufacturing fourth-generation refrigerants at Dahej, Gujarat, or an alternative suitable location.

This initiative aligns with SRF's focus on sustainable growth, as these refrigerants will have significantly lower global warming potential, contributing to a reduced carbon footprint.

The plant is expected to be commissioned within 30 months.

Additionally, SRF is setting up a manufacturing facility for BOPP-BOPE films in Indore, further expanding its packaging business.

This project, with an investment of Rs 445 m, is expected to be completed in 25 months and will be funded through a mix of debt and internal accruals.

The venture marks SRF's entry into new substrates, strengthening its presence in adjacent business segments.

Conclusion

India's chemical sector is poised for significant expansion, with projections from IBEF estimating its growth to US$ 300 bn by 2030 and reaching US$ 1 tn by 2040. The demand for chemicals is expected to rise at an annual rate of 9% by 2025, driven by both domestic and international consumption.

The country has long held a dominant position in the global generics and biosimilars market, with Indian vaccine manufacturers contributing over 50% of the world's vaccine supply.

This growth trajectory is fuelled by advancements in chemical technology, a shift toward high-value chemicals, and rising global demand.

Additionally, disruptions in the global supply chain, particularly due to geopolitical tensions and stringent regulations in China, have created a favourable environment for Indian chemical companies. With many global players seeking alternative sources for raw materials, India is emerging as a preferred supplier.

Further bolstering this momentum, the Indian government continues to support the sector through initiatives like Make in India and reductions in basic customs duties on key products, fostering a strong foundation for SRF's future growth.

However, investors should evaluate these companies' fundamentals, corporate governance, and valuations of the stocks as key factors when conducting due diligence before making investment decisions.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...